Skip to main content
SpringerLink
Log in

An industry imperiled by regulatory bottlenecks

  • Commentary
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1

© Mark Sokoloff

References

  • Devices & Diagnostics Letter 06 22 p2 (2001).

  • The Lewin Group. Report 4, Outlook for medical technology innovation (Falls Church, VA, 2001).

Download references

Author information

Authors and Affiliations

  1. Advanced Tissue Sciences, La Jolla, CA

    Gail Naughton (president)

Authors
  1. Gail Naughton
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Naughton, G. An industry imperiled by regulatory bottlenecks. Nat Biotechnol 19, 709–710 (2001). https://doi.org/10.1038/90735

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/90735

  • Springer Nature America, Inc.

Search

Navigation